Yael Capital is a technology-focused global venture capital firm focusing on global life science, hard tech, and impact investments. We commit professional expertise, industry resources, and long-term capital to empower revolutionary ideas and help exceptional entrepreneurs build enterprises contributing to human health and the long-term prosperity of society.
Our portfolios include: XtalPi, Xbiome, B.A.I Technologies, Edge Medical Robotics, Signet Therapeutics, MeTis Pharmaceuticals, Xellar Inc, AxBio International, META Pharmaceuticals, etc.
Please follow our Wechat account: Yael Capital for more information.
Company Details
- Founded
- 2018
- Address
- 77 Massachusetts Ave, Cambridge,massachusetts 02139,united States
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- HQ
- Cambridge, Massachusetts
Yael Capital 雅亿资本 Questions
Yael Capital 雅亿资本's LinkedIn profile is https://www.linkedin.com/company/yaelcapital
Yael Capital 雅亿资本's industry is
Venture Capital and Private Equity Principals
Yael Capital 雅亿资本's top competitors are
Grc Sinogreen Fund,
Innoforce Pharmaceuticals,
Cell Rising Capital,
K2 Venture Partners 险峰淇云,
Spade Capital（黑桃资本）,
3e Bioventures Capital,
Xty Capital,
Liquidity Capital 流动资本,
Fermi Ventures,
Sherpa Healthcare Partners (夏尔巴投资).
Yael Capital 雅亿资本's categories are Venture Capital and Private Equity Principals
Yael Capital 雅亿资本's founding year is 2018
